SABBY 13G BCLI 2.02.15

Company

BRAINSTORM CELL THERAPEUTICS INC.

Filed

February 2, 2015

Accession Number

0001535610-15-000042

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →